Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families

Nutrition Journal

Table 2 Serum 25[OH] vitamin D by Groups

Group*	Serum Vit 25(OH) D	Replete: ≥ 75	Insufficient: 50-74	Deficient: < 50
Group*	mean ± SD	n (%)	n (%)	n (%)
IBD Patients	71.2 ± 32.8**	21 (38.2%)	12 (21.8%)	17 (30.9%)
IBD Patients	71.2 ± 32.8**	15(71.4%)	3 (25%)	8 (47.1%)
Crohn’s Disease	71.1 ± 31.1	14 (41.2%)	7 (20.6%)	10 (29.4%)
Crohn’s Disease	71.1 ± 31.1	9 (64.3%)	2 (28.6%)	5 (50%)
Ulcerative Colitis	71.4 ± 36.3	7 (33.3%)	5 (23.8%)	7 (33.3%)
Ulcerative Colitis	71.4 ± 36.3	6 (85.7%)	1 (20%)	3 (42.9%)
Patients’ Family	82.3 ± 34.2	27 (49.1%)	18 (32.7%)	7 (12.7%)
Patients’ Family	82.3 ± 34.2	13 (48.2%)	5 (27.8%)	1 (14.3%)
Healthy Control	68.3 ± 26.2	15 (31.3%)	19 (39.6%)	11 (22.9%)
Healthy Control	68.3 ± 26.2	7 (46.7%)	11 (57.9%)	4 (36.4%)
Controls’ Family	69.9 ± 27.6	19 (39.6%)	16 (33.3%)	11 (22.9%)
Controls’ Family	69.9 ± 27.6	8 (88.9%)	5 (31.3%)	1 (9.1%)

Levels and categories of serum 25[OH] vitamin D in nmol/L overall and by patient, control and their respective families are shown. The lower values represent the number of participants in each category who consumed supplemental vitamin D and the percentage of the category in each group. Based on (n = 193) available serum levels.
* Because of some missing data on serum 25[OH] vitamin D levels, percentages do not sum to 100%. Missing data were as follows:
5 from IBD.
3 from Family IBD.
3 from Control.
2 from Family Control.
** patient vs. family: p = 0.0332 (paired t test) or p = 0.0164 (for log values).

ISSN: 1475-2891